Biosynex SA (ALBIO) Financial Statements

2 Followers

Biosynex SA Financial Overview

Biosynex SA's market cap is currently €21.28M. The company's EPS TTM is €-3.65; its P/E ratio is -0.19; Biosynex SA is scheduled to report earnings on ―, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	€ 95.20M	€ 101.20M	€ 92.98M	€ 196.59M	€ 382.53M
Gross Profit	€ -3.60M	€ -20.00M	€ 49.13M	€ 64.52M	€ 182.55M
Operating Income	€ -4.70M	€ -21.10M	€ -37.40M	€ 38.86M	€ 140.65M
EBITDA	€ -4.70M	€ -17.83M	€ -10.18M	€ 46.73M	€ 146.60M
Net Income	€ -58.20M	€ -43.30M	€ -36.95M	€ 15.66M	€ 104.00M
Balance Sheet
Cash & Short-Term Investments	€ 8.46M	€ 9.69M	€ 26.16M	€ 87.17M	€ 132.03M
Total Assets	€ 136.24M	€ 194.69M	€ 241.73M	€ 259.98M	€ 268.94M
Total Debt	€ 61.65M	€ 62.46M	€ 65.60M	€ 52.07M	€ 35.31M
Net Debt	€ 53.19M	€ 57.77M	€ 45.43M	€ -35.10M	€ -96.72M
Total Liabilities	€ 101.29M	€ 114.19M	€ 117.41M	€ 93.21M	€ 101.14M
Stockholders' Equity	€ 34.95M	€ 80.58M	€ 124.48M	€ 162.40M	€ 167.81M
Cash Flow
Free Cash Flow	€ -8.57M	€ -14.96M	€ -49.20M	€ -25.13M	€ 90.82M
Operating Cash Flow	€ -5.89M	€ -10.12M	€ -9.65M	€ 4.95M	€ 109.83M
Investing Cash Flow	€ 3.04M	€ -4.60M	€ -54.81M	€ -39.08M	€ -28.96M
Financing Cash Flow	€ 6.91M	€ -801.00K	€ 5.17M	€ -10.81M	€ 14.40M

Currency in EUR

Biosynex SA Earnings and Revenue History

Income Statement >

Biosynex SA Debt to Assets

Balance Sheet >

Biosynex SA Cash Flow

Cash Flow >

Biosynex SA Forecast EPS vs Actual EPS

Currently, no data available

Please return soon. This page is being updated.

Earnings >